Frank Ziemann

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Community: Component based differential cell communication analysis in large multi-sample case-control scRNAseq datasets.

Community: Component based differential cell communication analysis in large multi-sample case-control scRNAseq datasets.

Journal: iScience

Published: May 06, 2026

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Journal: Leukemia

Published: March 18, 2026

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

Journal: The New England journal of medicine

Published: March 04, 2026

Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.

Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.

Journal: HemaSphere

Published: March 11, 2025

A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.

A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.

Journal: Targeted oncology

Published: July 13, 2023

Modeling early treatment response in AML from cell-free tumor DNA.

Modeling early treatment response in AML from cell-free tumor DNA.

Journal: iScience

Published: June 16, 2023

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.

Journal: Neuro-oncology advances

Published: June 08, 2023

Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic

Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic

Journal: Deutsche medizinische Wochenschrift (1946)

Published: March 29, 2023

Aetiology and diagnostic of leucocytosis

Aetiology and diagnostic of leucocytosis

Journal: MMW Fortschritte der Medizin

Published: January 17, 2023

Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.

Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.

Journal: Molecular cancer

Published: October 01, 2022

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.

Journal: Journal of cancer research and clinical oncology

Published: March 24, 2022

Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNA.

Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNA.

Journal: The Journal of molecular diagnostics : JMD

Published: February 03, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026